JP2000514060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000514060A5 JP2000514060A5 JP1998504196A JP50419698A JP2000514060A5 JP 2000514060 A5 JP2000514060 A5 JP 2000514060A5 JP 1998504196 A JP1998504196 A JP 1998504196A JP 50419698 A JP50419698 A JP 50419698A JP 2000514060 A5 JP2000514060 A5 JP 2000514060A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67439196A | 1996-07-01 | 1996-07-01 | |
| US08/674,391 | 1996-07-01 | ||
| PCT/US1997/010696 WO1998000412A1 (en) | 1996-07-01 | 1997-06-26 | Muscarinic antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008194199A Division JP2009040778A (ja) | 1996-07-01 | 2008-07-28 | ムスカリン様アンタゴニスト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000514060A JP2000514060A (ja) | 2000-10-24 |
| JP2000514060A5 true JP2000514060A5 (enExample) | 2005-03-10 |
Family
ID=24706404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10504196A Ceased JP2000514060A (ja) | 1996-07-01 | 1997-06-26 | ムスカリン様アンタゴニスト |
| JP2008194199A Pending JP2009040778A (ja) | 1996-07-01 | 2008-07-28 | ムスカリン様アンタゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008194199A Pending JP2009040778A (ja) | 1996-07-01 | 2008-07-28 | ムスカリン様アンタゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0912534B1 (enExample) |
| JP (2) | JP2000514060A (enExample) |
| KR (1) | KR20000022380A (enExample) |
| AT (1) | ATE224884T1 (enExample) |
| AU (1) | AU717431B2 (enExample) |
| CA (1) | CA2258044C (enExample) |
| DE (1) | DE69715865T2 (enExample) |
| ES (1) | ES2179353T3 (enExample) |
| HU (1) | HUP9904167A3 (enExample) |
| IL (1) | IL127858A0 (enExample) |
| NZ (1) | NZ333322A (enExample) |
| WO (1) | WO1998000412A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726736D0 (en) * | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Chemical compounds |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| GB9914015D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| JP2002533447A (ja) * | 1998-12-24 | 2002-10-08 | アストラゼネカ・アクチエボラーグ | 神経疾患の治療に有用な１，４−ジアザシクロヘプタン誘導体 |
| GB9900078D0 (en) * | 1999-01-05 | 1999-02-24 | Zeneca Ltd | Chemical compounds |
| GB9914022D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| GB9914024D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| GB9914025D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
| BR0214649A (pt) * | 2001-12-03 | 2004-11-03 | Hoffmann La Roche | Derivados de aminotetralina como antagonistas do receptor muscarìnico |
| WO2004048322A1 (en) | 2002-11-25 | 2004-06-10 | Schering Corporation | Cannabinoid receptor ligands |
| WO2005037830A1 (en) | 2003-10-10 | 2005-04-28 | Wyeth | Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| ES2431524T3 (es) * | 2004-04-13 | 2013-11-26 | Incyte Corporation | Derivados de piperazinilpiperidina como antagonistas de los receptores de quimiocinas |
| US7378415B2 (en) | 2004-09-30 | 2008-05-27 | Roche Palo Alto Llc | Benzoxazine and quinoxaline derivatives and uses thereof |
| BRPI0515835A (pt) * | 2004-12-21 | 2008-08-12 | Hoffmann La Roche | derivados de tetralina e de indano e seus usos |
| WO2006102958A1 (en) * | 2005-03-29 | 2006-10-05 | Newron Pharmaceuticals S.P.A. | Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| ATE499355T1 (de) | 2005-11-03 | 2011-03-15 | Hoffmann La Roche | Arylsulfonylchromane als 5-ht6-inhibitoren |
| KR101064001B1 (ko) | 2006-06-20 | 2011-09-08 | 에프. 호프만-라 로슈 아게 | 아릴설폰아미딜 테트랄린 유도체 및 이의 용도 |
| CA2653758A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
| WO2007147763A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
| WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| AU2011216950A1 (en) | 2010-02-16 | 2012-08-23 | Pfizer Inc. | (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors |
| WO2017015349A1 (en) * | 2015-07-20 | 2017-01-26 | Chase Pharmaceuticals Corporation | Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for treating hypocholinergic disorders |
| MX386501B (es) * | 2015-09-28 | 2025-03-19 | Genentech Inc | Compuestos terapeuticos y sus metodos de uso |
| WO2023283425A1 (en) | 2021-07-09 | 2023-01-12 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD113545A5 (enExample) * | 1973-03-30 | 1975-06-12 | ||
| DE3064285D1 (en) * | 1979-09-28 | 1983-08-25 | Beecham Group Plc | Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them |
| DK691488A (da) * | 1987-12-14 | 1989-06-15 | Beecham Group Plc | Hidtil ukendte forbindelser |
| DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
| ES2164054T3 (es) * | 1991-11-05 | 2002-02-16 | Smithkline Beecham Corp | Antagonistas de receptores de endotelina. |
| WO1994012493A1 (en) * | 1992-11-25 | 1994-06-09 | Sandoz, Ltd. | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals |
-
1997
- 1997-06-26 AT AT97931281T patent/ATE224884T1/de not_active IP Right Cessation
- 1997-06-26 HU HU9904167A patent/HUP9904167A3/hu unknown
- 1997-06-26 NZ NZ333322A patent/NZ333322A/en unknown
- 1997-06-26 DE DE69715865T patent/DE69715865T2/de not_active Expired - Fee Related
- 1997-06-26 KR KR1019980710811A patent/KR20000022380A/ko not_active Withdrawn
- 1997-06-26 JP JP10504196A patent/JP2000514060A/ja not_active Ceased
- 1997-06-26 EP EP97931281A patent/EP0912534B1/en not_active Expired - Lifetime
- 1997-06-26 AU AU34953/97A patent/AU717431B2/en not_active Ceased
- 1997-06-26 WO PCT/US1997/010696 patent/WO1998000412A1/en not_active Ceased
- 1997-06-26 ES ES97931281T patent/ES2179353T3/es not_active Expired - Lifetime
- 1997-06-26 IL IL12785897A patent/IL127858A0/xx unknown
- 1997-06-26 CA CA002258044A patent/CA2258044C/en not_active Expired - Fee Related
-
2008
- 2008-07-28 JP JP2008194199A patent/JP2009040778A/ja active Pending